IL-1 is elevated in experimental glomerular disease and administration of IL-1 accentuates the renal injury, associated with directly stimulating the proliferation of mesangial cells, as well as indirectly exacerbating injury by increasing the production of other inflammatory mediators such as IL-6, TNF-α and ICAM [59]–[61]. Here, IL1A is linked to glomerular disorder.